share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Joyner J. David

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Joyner J. David

西维斯健康 | 4:持股变动声明-高管 Joyner J. David
美股SEC公告 ·  12/03 17:16

Moomoo AI 已提取核心信息

Joyner J. David, President and CEO of CVS Health, completed a transaction involving the sale of common stock on 11/30/2024. The transaction involved a total of 84,922 shares, with 40,681 shares of common stock and 44,241 shares of restricted common stock held directly after the transaction.The transaction reflects a strategic decision by the CEO, impacting the company's stock holdings. The direct ownership form was maintained for both common and restricted stocks. This move is significant for investors monitoring executive stock transactions, as it may influence market perceptions and stock performance.Investors should consider the implications of this transaction on CVS Health's market position and potential future strategies.
Joyner J. David, President and CEO of CVS Health, completed a transaction involving the sale of common stock on 11/30/2024. The transaction involved a total of 84,922 shares, with 40,681 shares of common stock and 44,241 shares of restricted common stock held directly after the transaction.The transaction reflects a strategic decision by the CEO, impacting the company's stock holdings. The direct ownership form was maintained for both common and restricted stocks. This move is significant for investors monitoring executive stock transactions, as it may influence market perceptions and stock performance.Investors should consider the implications of this transaction on CVS Health's market position and potential future strategies.
CVS Health总裁兼首席执行官乔伊纳·戴维于2024年11月30日完成了一项涉及普通股出售的交易。该交易共涉及84,922股,交易后直接持有40,681股普通股和44,241股限制性普通股。该交易反映了首席执行官的战略决策,影响了公司的股票持有量。普通股和限制性股票均维持直接所有权形式。此举对于监督高管股票交易的投资者来说意义重大,因为它可能会影响市场认知和股票表现。投资者应考虑该交易对CVS Health的市场地位和潜在的未来策略的影响。
CVS Health总裁兼首席执行官乔伊纳·戴维于2024年11月30日完成了一项涉及普通股出售的交易。该交易共涉及84,922股,交易后直接持有40,681股普通股和44,241股限制性普通股。该交易反映了首席执行官的战略决策,影响了公司的股票持有量。普通股和限制性股票均维持直接所有权形式。此举对于监督高管股票交易的投资者来说意义重大,因为它可能会影响市场认知和股票表现。投资者应考虑该交易对CVS Health的市场地位和潜在的未来策略的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息